JORGE E CORTES to Genetic Predisposition to Disease
This is a "connection" page, showing publications JORGE E CORTES has written about Genetic Predisposition to Disease.
Connection Strength
0.069
-
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial. J Clin Oncol. 2018 01 20; 36(3):231-237.
Score: 0.057
-
Treatment selection after imatinib resistance in chronic myeloid leukemia. Target Oncol. 2009 Jan; 4(1):3-10.
Score: 0.008
-
Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia. Cancer. 2001 May 01; 91(9):1704-8.
Score: 0.005